Navigating the regulatory landscape for dietary supplements is crucial for brands bringing products to market. While both the United States and the European Union have robust frameworks, their approaches to labeling requirements for gummy supplements differ significantly in philosophy and specific mandates. Understanding these distinctions is key to ensuring compliance and building consumer trust.
Regulatory Foundations
The core difference lies in the foundational regulatory approach. In the US, dietary supplements, including gummies, are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994, administered by the Food and Drug Administration (FDA). The system is largely post-market, meaning the FDA generally does not approve products before they are sold but takes action against non-compliant products.
In the EU, gummy supplements are classified as food supplements under the Food Supplements Directive (2002/46/EC). Regulation is more harmonized and pre-market in nature, with stricter controls on permissible ingredients, especially vitamins and minerals, and often requires notification to national authorities before a product is placed on the market.
Key Labeling Requirement Differences
1. Ingredient Lists & Nutrient Declarations
- US (FDA): Requires a "Supplement Facts" panel, which lists dietary ingredients, amounts per serving, and % Daily Value (%DV) where established. Proprietary blends must list total weight and individual ingredients in descending order of predominance.
- EU: Requires a "Nutrition Information" panel similar to food, but for supplements, it must list the amount of each vitamin/mineral and other substance present, often expressed in absolute amounts. The declaration must also show the nutrient's amount as a percentage of the Nutrient Reference Value (NRV).
2. Health & Structure/Function Claims
- US (FDA): Permits structure/function claims (e.g., "supports immune health") without pre-approval, but they must be truthful, not misleading, and accompanied by a disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Explicit disease claims are prohibited.
- EU: Has a much stricter, centralized system. Only health claims that have been scientifically assessed and authorized by the European Food Safety Authority (EFSA) and included on the EU's permitted list can be used. The list is limited, making approved claims for supplements fewer and more generic (e.g., "Vitamin C contributes to the normal function of the immune system").
3. Ingredient Safety & Novel Foods
- US (FDA): Under DSHEA, ingredients marketed in the US before 1994 are generally considered "grandfathered" and can be used. New Dietary Ingredients (NDIs) require a pre-market safety notification to the FDA.
- EU: Maintains positive lists for permitted vitamins, minerals, and their forms. Any other substance (like botanicals or novel compounds) not commonly consumed in the EU before 1997 is considered a Novel Food and requires a stringent pre-market safety assessment and authorization before it can be used in a supplement.
4. Additional Mandatory Statements
- US (FDA): Requires the statement "Dietary Supplement," the name and place of business of the manufacturer, packer, or distributor, and a disclaimer on structure/function claims as noted above.
- EU: Requires specific statements including: "Food supplements should not be used as a substitute for a varied diet" and "Keep out of reach of young children." Warnings about exceeding the stated daily dose are also mandatory if applicable.
Summary Table
| Requirement | United States (FDA/DSHEA) | European Union (EFSA/Directive) |
|---|---|---|
| Core Panel | Supplement Facts | Nutrition Information (with %NRV) |
| Claim Regulation | Permits structure/function claims with disclaimer; prohibits disease claims. | Only pre-approved, authorized health claims from the EU list are permitted. |
| Ingredient Approval | Post-market for grandfathered ingredients; NDI notification for new ones. | Pre-market approval for vitamins/minerals (positive lists) and Novel Foods. |
| Mandatory Statements | "Dietary Supplement," business info, DSHEA disclaimer on claims. | "Not a substitute for a varied diet," "Keep out of reach of children," dose warnings. |
In conclusion, while both regions aim to protect consumers, the EU employs a more precautionary and harmonized pre-market model with strictly controlled claims, whereas the US operates on a post-market model that allows more flexibility in claims and ingredient use, placing significant responsibility on the manufacturer. For any brand, meticulous attention to these regional specifics is non-negotiable for successful market entry and compliance.